You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Dopamine receptors

Showing 1 - 25 of 2,837
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Functional Relevance of Dopamine Receptors in Healthy Controls

Recruiting
  • Schizoaffective Disorder
  • Schizophrenia
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 24, 2022

    Alcohol Use Disorder Trial in Toronto ([11C]-(+)-PHNO PET scan, Alcohol Self-Administration, Craving Task)

    Completed
    • Alcohol Use Disorder
    • [11C]-(+)-PHNO PET scan
    • +4 more
    • Toronto, Ontario, Canada
      Centre for Addiction and Mental Health
    Oct 27, 2020

    The Meaning of Dopaminergic Pathway in Sleep Breathing

    Enrolling by invitation
    • Sleep Apnea
    • Sleep-Disordered Breathing
    • Polysomnography
    • +2 more
    • Wroclaw, Poland
      Wroclaw Medical Uniwesity
    May 25, 2023

    Disorder of Consciousness, Traumatic Brain Injury Trial in New York (Amantadine + L-DOPA, NMDA blocker)

    Suspended
    • Disorder of Consciousness
    • Traumatic Brain Injury
    • Amantadine + L-DOPA
    • NMDA blocker
    • New York, New York
      Weill Cornell Medicine
    Sep 27, 2022

    Parkinson Disease, Treatment Adherence Trial in Ankara (Levodopa)

    Enrolling by invitation
    • Parkinson Disease
    • Treatment Adherence
    • Ankara, Turkey
      Ankara Atatürk Sanatorium Training and Research Hospital
    Oct 30, 2023

    Pathophysiology of Gilles de la Tourette Syndrome. Part 1:

    Not yet recruiting
    • Gilles de la Tourette Syndrome
    • Tourette Syndrome
    • PET/MR scanner
    • Leipzig, Germany
      Max Planck Institute for Human Cognitive and Brain Sciences
    Feb 11, 2022

    Cocaine Abuse Trial run by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) (Brain Dopamine Reactivity, Brain

    Suspended
    • Cocaine Abuse
    • Brain Dopamine Reactivity
    • Brain Dopamine Receptor
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 24, 2022

    Diabetes, Type 2 Trial in Tuebingen (intranasal insulin, Placebo)

    Recruiting
    • Diabetes Mellitus, Type 2
    • intranasal insulin
    • Placebo
    • Tuebingen, Germany
      University of Tuebingen, Department of Internal Medicine IV
    Jun 24, 2021

    Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder Trial in Toronto (Risperidone/Olanzapine and PET scans)

    Completed
    • Schizophrenia
    • +4 more
    • Risperidone/Olanzapine and PET scans
    • Toronto, Ontario, Canada
      Centre for Addiction and Mental Health
    Jun 2, 2022

    Dopaminergic Receptors in Sydenham's Chorea

    Unknown status
    • Sydenham Chorea
    • Strep Throat
    • Antibody detection
    • Jerusalem, Israel
      Shaare Zedek Medical center
    Sep 8, 2019

    Parkinson Disease Trial in Lille (A-dopamine, optimized oral treatment)

    Recruiting
    • Parkinson Disease
    • Lille, France
      Hopital Roger Salengro, CHU Lille
    Oct 11, 2022

    Cocaine Use Disorder Trial in Pittsburgh (Baseline [C-11]NPA PET Scan, d-amphetamine, Post-amphetamine [C-11]NPA PET Scan)

    Recruiting
    • Cocaine Use Disorder
    • Baseline [C-11]NPA PET Scan
    • +2 more
    • Pittsburgh, Pennsylvania
      University of PIttsburgh
    Jun 27, 2022

    Pathophysiology of Gilles de la Tourette Syndrome. Part 2: 7T

    Recruiting
    • Gilles de la Tourette Syndrome
    • Tourette Syndrome
    • MRI scanner (7 Tesla)
    • Leipzig, Germany
      Max Planck Institute for Human Cognitive and Brain Sciences
    Feb 10, 2022

    Idiopathic Parkinson's Disease Trial in Pozzilli (PD patients H&Y=1.5-2 Medications ON, PD patients H&Y=1.5-2 Medications OFF,

    Recruiting
    • Idiopathic Parkinson's Disease
    • PD patients H&Y=1.5-2 Medications ON
    • +4 more
    • Pozzilli, Isernia, Italy
      IRCSS Neuromed Hospital
    May 18, 2022

    Depressive Disorder, Major Trial (Cariprazine, Treatment as usual)

    Not yet recruiting
    • Depressive Disorder, Major
    • (no location specified)
    Jul 5, 2023

    Dopamine D2/3 Receptor Availability, Cognitive Function, Methamphetamine Abuse Trial in Los Angeles (Varenicline, Placebo)

    Enrolling by invitation
    • Dopamine D2/3 Receptor Availability
    • +2 more
    • Los Angeles, California
      University of California Los Angeles
    Mar 2, 2022

    Placebo Effect on Mood Improvement Trial in Marburg (Sulpiride 400 MG, Placebo, High expectation manipulation)

    Recruiting
    • Placebo Effect on Mood Improvement
    • Sulpiride 400 MG
    • +3 more
    • Marburg, Hessen, Germany
      Department of Psychology, Differential Psychology and Personalit
    Jan 13, 2022

    Traumatic Brain Injury Trial in Cairo (Cerebrolysin, amantadine sulfate)

    Recruiting
    • Traumatic Brain Injury
    • Cairo, Egypt
      Faculty of medicine - Ain shams university
    Sep 26, 2023

    Depression Trial in Roma, Rome (Vortioxetine)

    Recruiting
    • Depression
    • Roma, Italy
    • +1 more
    Oct 17, 2022

    Caffeine Trial in Basel (caffeine, mannitol)

    Recruiting
    • Caffeine
    • caffeine
    • mannitol
    • Basel, Basel City, Switzerland
      Centre for Chronobiology, University Psychiatric Clinics Basel
    May 20, 2022

    Brachial Plexus Injury Trial in Rochester (Ketamine Infustion)

    Enrolling by invitation
    • Brachial Plexus Injury
    • Ketamine Infustion
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Dec 29, 2022

    Schizophrenia Spectrum Disorders Trial (Oxytocin, Placebo)

    Not yet recruiting
    • Schizophrenia Spectrum Disorders
    • Oxytocin
    • Placebo
    • (no location specified)
    Nov 13, 2023

    Stimulant Use and Methylation in HIV

    Completed
    • HIV Infections
    • +2 more
      • Miami, Florida
        University of Miami
      Jun 14, 2023

      Schizophrenia, Glucose Intolerance Trial in Pittsburgh (Bromocriptine)

      Not yet recruiting
      • Schizophrenia
      • Glucose Intolerance
      • Pittsburgh, Pennsylvania
        VA Pittsburgh Healthcare System
      Oct 11, 2022

      High Grade Glioma, Meningioma, Embryonal Tumor Trial in United States (LUTATHERA® (Lutetium Lu 177 dotatate))

      Recruiting
      • High Grade Glioma
      • +12 more
      • LUTATHERA® (Lutetium Lu 177 dotatate)
      • Aurora, Colorado
      • +8 more
      Jan 16, 2023